These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 16316716
1. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients. Wong JO, Leung SP, Mak T, Ng RM, Chan KT, Hon-Kee Cheung H, Choi WK, Lai J, Wai-Kiu Tsang A. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716 [Abstract] [Full Text] [Related]
2. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP, Poonkuzhali B, Kuruvilla A, Jacob M, Jacob KS. Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [Abstract] [Full Text] [Related]
3. Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients. Repo-Tiihonen E, Eloranta A, Hallikainen T, Tiihonen J. Neuropsychobiology; 2005 Jan; 51(4):173-6. PubMed ID: 15870506 [Abstract] [Full Text] [Related]
4. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. Llorca PM, Lancon C, Disdier B, Farisse J, Sapin C, Auquier P. J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974 [Abstract] [Full Text] [Related]
5. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. Miller DD, Fleming F, Holman TL, Perry PJ. J Clin Psychiatry; 1994 Sep; 55 Suppl B():117-21. PubMed ID: 7961554 [Abstract] [Full Text] [Related]
6. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance. Adler G, Grieshaber S, Faude V, Thebaldi B, Dressing H. Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790 [Abstract] [Full Text] [Related]
7. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Perry PJ, Miller DD, Arndt SV, Cadoret RJ. Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979 [Abstract] [Full Text] [Related]
8. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B. J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557 [Abstract] [Full Text] [Related]
9. Predictors of clinical outcome in schizophrenic patients responding to clozapine. Mauri MC, Volonteri LS, Dell'Osso B, Regispani F, Papa P, Baldi M, Bareggi SR. J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196 [Abstract] [Full Text] [Related]
10. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Freudenreich O, Weiner RD, McEvoy JP. Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730 [Abstract] [Full Text] [Related]
11. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G. Pharmacopsychiatry; 2008 Jan 15; 41(1):24-8. PubMed ID: 18203048 [Abstract] [Full Text] [Related]
12. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Kronig MH, Munne RA, Szymanski S, Safferman AZ, Pollack S, Cooper T, Kane JM, Lieberman JA. Am J Psychiatry; 1995 Feb 15; 152(2):179-82. PubMed ID: 7840349 [Abstract] [Full Text] [Related]
13. [Clinical follow-up -- EEG -- serum determinations: therapeutic experience with clozapine]. Gekiere F, Dessalles MC, Poisson N, Maitre L. Encephale; 1996 Dec 15; 22 Spec No 6():16-23. PubMed ID: 9102314 [Abstract] [Full Text] [Related]
14. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence]. Fleischhaker C, Schulz E, Remschmidt H. Z Kinder Jugendpsychiatr Psychother; 1998 Dec 15; 26(4):235-43. PubMed ID: 9880833 [Abstract] [Full Text] [Related]
15. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026 [Abstract] [Full Text] [Related]
16. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G. Biol Psychiatry; 2006 Sep 15; 60(6):645-9. PubMed ID: 16780811 [Abstract] [Full Text] [Related]
17. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia AG, Ventimiglia A, Perucca E. Psychopharmacology (Berl); 2000 Jan 15; 148(1):83-9. PubMed ID: 10663421 [Abstract] [Full Text] [Related]
18. [Toxic plasma concentration of clozapine in inflammatory processes]. van Gool AR, de Jong MH, Verhoeven WM. Tijdschr Psychiatr; 2010 Jan 15; 52(11):791-6. PubMed ID: 21064022 [Abstract] [Full Text] [Related]
19. Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients. Shen H, Li R, Xiao H, Zhou Q, Cui Q, Chen J. J Psychiatr Res; 2009 Mar 15; 43(6):615-9. PubMed ID: 18976782 [Abstract] [Full Text] [Related]
20. Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients. Stieffenhofer V, Saglam H, Schmidtmann I, Silver H, Hiemke C, Konrad A. Pharmacopsychiatry; 2011 Mar 15; 44(2):55-9. PubMed ID: 21207352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]